Chakraborty G, Patail NK, Hirani R, Nandakumar S, et al. Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors. Clin Cancer Res 2021;27:1792-1806.
PMID: 33334906